Results 31 to 40 of about 3,101,855 (192)

Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy [PDF]

open access: yesCirculation, 2003
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a disease characterized by fatty replacement of the right ventricular muscle (1). The residual myocardial fibers are often embedded in fibrous tissue. This substrate is conducive to right ventricular re-entrant arrhythmias. Initially this condition was called dysplasia because it was
Kathleen, Gear, Frank, Marcus
openaire   +2 more sources

Analysis of desmoplakin in arrythmogenic right ventricular cardiomyopathy [PDF]

open access: yes, 2010
Includes bibliographical references (leaves 71-79).It has been shown that all forms of cardiomyopathy, including the dilated, hypertrophic, restrictive, and right ventricular arrhythmogenic forms, are found in African populations.
Fish, Maryam
core   +1 more source

Arrhythmogenic Right Ventricular Dysplasia — a Variant of Primary Cardiomyopathy

open access: yesZdorovʹe Rebenka, 2013
This article provides an own observation of family form of arrhytmogenic right ventricular dysplasia in a girl, which had been followed-up for 12 years.
G.E. Sukhareva, V.I. Sadovoy
doaj   +1 more source

Arrhythmogenic right ventricular cardiomyopathy/dysplasia

open access: yesBratislava Medical Journal, 2005
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a progressive disease of predominantly right ventricle, characterized by ventricular arrhythmias possible leading to sudden cardiac death. Genetic predisposition was confirmed more than 15 years ago. Autosomal dominant are forms ARVD1-9, Naxos disease (with subtype Carvajal syndrome)
S, Navarcikova   +3 more
openaire   +2 more sources

Molecular genetics of arrhythmogenic right ventricular cardiomyopathy in South Africa [PDF]

open access: yes, 2011
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable disorder characterised by progressive degeneration of the right ventricular myocardium, arrhythmias and an increased risk of sudden death at a young age. Fourteen chromosomal loci have
Blanckenberg, Janine
core   +1 more source

Left Ventricular Dysfunction in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Can We Separate ARVC From Other Arrhythmogenic Cardiomyopathies?

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Arrhythmogenic right ventricular cardiomyopathy was first described as a right ventricular disease that is an important cause of death in young adults. However, with the advent of advanced imaging, arrhythmogenic right ventricular cardiomyopathy has been
Stephan Altmayer   +2 more
doaj   +1 more source

Evolution of diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy and their application in clinical practice

open access: yesРоссийский кардиологический журнал, 2021
This article describes evolution of criteria for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). The novel diagnostic criteria for ARVD/C published in 2020 are analyzed in detail, among which biventricular and leftdominant ...
Yu. A. Lutokhina   +5 more
doaj   +1 more source

Arrhythmogenic right ventricular cardiomyopathy/dysplasia

open access: yes, 2016
Arrhythmogenic right ventricular cardiomyopathy (dysplasia) is discussed. Diagnosis and indications for ICD therapy are presented.
Bernard J. Gersh   +2 more
core   +1 more source

A novel treatment strategy for therapy refractory ventricular arrhythmias in the setting of arrhythmogenic right ventricular dysplasia [PDF]

open access: yes, 2007
Arrhythmogenic right ventricular dysplasia (ARVD) is a major cause of ventricular tachycardia and cardiac arrest in young adults. The ideal management of this genetic disorder is individual.
Pedro Brugada   +9 more
core   +1 more source

Complementary Yield of Gene Panel Testing and ACMG SF v3.3 Screening for Cardiovascular Disease in a Korean Cohort

open access: yesClinical Genetics, EarlyView.
Phenotype‐directed gene panel testing and opportunistic ACMG SF v3.3 screening identified distinct, complementary cardiovascular genetic risks in a Korean cohort. Panel testing achieved a 20.0% yield enriched for arrhythmia/cardiomyopathy genes, whereas opportunistic exome screening revealed a 5.6% yield dominated by TTN‐related cardiomyopathy and ...
Jihye You   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy